Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Tavis

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Antiviral Research|April 29, 2017
Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocyclesTiffany C Edwards, Elena Lomonosova, Jenny A Patel, et al.
Journal of Virology|February 3, 2007
Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapyMilton W Taylor, Takuma Tsukahara, Leonid Brodsky, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex VirusesPeter J Ireland, John E Tavis, Michael P D'Erasmo, et al.
Plos One|August 5, 2020
Diversity of the hepatitis C virus NS5B gene during HIV co-infectionTshegofatso Ngwaga, Ling Kong, Derrick Lin, et al.
Bioorganic Chemistry|October 20, 2022
Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulatorsShuo Wang, Yujie Ren, Qilan Li, et al.
Antiviral Research|November 14, 2017
Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric miceKelly R Long, Elena Lomonosova, Qilan Li, et al.
The Journal of Clinical Investigation|January 14, 2009
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune responseEva Dazert, Christoph Neumann-Haefelin, Stéphane Bressanelli, et al.
ACS Omega|April 5, 2021
Synthetic Derivatives of Ciclopirox are Effective Inhibitors of <i>Cryptococcus neoformans</i>Jeffrey Lin, Maryam Zangi, Tanguturi Venkata Narayana Hajay Kumar, et al.
RSC Advances|October 12, 2020
Divergent synthesis of a thiolate-based α-hydroxytropolone library with a dynamic bioactivity profileNana B Agyemang, Cassandra R Kukla, Tiffany C Edwards, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Antiviral Research|April 29, 2017
Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocyclesTiffany C Edwards, Elena Lomonosova, Jenny A Patel, et al.
Journal of Virology|February 3, 2007
Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapyMilton W Taylor, Takuma Tsukahara, Leonid Brodsky, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex VirusesPeter J Ireland, John E Tavis, Michael P D'Erasmo, et al.
Plos One|August 5, 2020
Diversity of the hepatitis C virus NS5B gene during HIV co-infectionTshegofatso Ngwaga, Ling Kong, Derrick Lin, et al.
Bioorganic Chemistry|October 20, 2022
Design, synthesis, and biological evaluation of novel sulfamoylbenzamide derivatives as HBV capsid assembly modulatorsShuo Wang, Yujie Ren, Qilan Li, et al.
Antiviral Research|November 14, 2017
Efficacy of hepatitis B virus ribonuclease H inhibitors, a new class of replication antagonists, in FRG human liver chimeric miceKelly R Long, Elena Lomonosova, Qilan Li, et al.
The Journal of Clinical Investigation|January 14, 2009
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune responseEva Dazert, Christoph Neumann-Haefelin, Stéphane Bressanelli, et al.
ACS Omega|April 5, 2021
Synthetic Derivatives of Ciclopirox are Effective Inhibitors of <i>Cryptococcus neoformans</i>Jeffrey Lin, Maryam Zangi, Tanguturi Venkata Narayana Hajay Kumar, et al.
RSC Advances|October 12, 2020
Divergent synthesis of a thiolate-based α-hydroxytropolone library with a dynamic bioactivity profileNana B Agyemang, Cassandra R Kukla, Tiffany C Edwards, et al.
Pageof 10